Department of Genetics and CNR-MAJ, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France.
Institut de Recherche en Infectiologie de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Mov Disord. 2020 Aug;35(8):1336-1345. doi: 10.1002/mds.28090. Epub 2020 Jun 7.
Primary familial brain calcification (PFBC) is a rare cerebral microvascular calcifying disorder with diverse neuropsychiatric expression. Five genes were reported as PFBC causative when carrying pathogenic variants. Haploinsufficiency of SLC20A2, which encodes an inorganic phosphate importer, is a major cause of autosomal-dominant PFBC. However, PFBC remains genetically unexplained in a proportion of patients, suggesting the existence of additional genes or cryptic mutations. We analyzed exome sequencing data of 71 unrelated, genetically unexplained PFBC patients with the aim to detect copy number variations that may disrupt the expression of core PFBC-causing genes.
After the identification of a deletion upstream of SLC20A2, we assessed its consequences on gene function by reverse transcriptase droplet digital polymerase chain reaction (RT-ddPCR), an ex vivo inorganic phosphate uptake assay, and introduced the deletion of a putative SLC20A2 enhancer mapping to this region in human embryonic kidney 293 (HEK293) cells by clustered regularly interspaced short palindromic repeats (CRISPR) - CRISPR-associated protein 9 (Cas9).
The 8p11.21 deletion, segregating with PFBC in a family, mapped 35 kb upstream of SLC20A2. The deletion carriers/normal controls ratio of relative SLC20A2 mRNA levels was 60.2% (P < 0.001). This was comparable with that of patients carrying an SLC20A2 premature stop codon (63.4%; P < 0.001). The proband exhibited a 39.3% decrease of inorganic phosphate uptake in blood (P = 0.015). In HEK293 cells, we observed a 39.8% decrease in relative SLC20A2 mRNA levels after normalization on DNA copy number (P < 0.001).
We identified a deletion of an enhancer of SLC20A2 expression, with carriers showing haploinsufficiency in similar ranges to loss-of-function alleles, and we observed reduced mRNA levels after deleting this element in a cellular model. We propose a 3-step strategy to identify and easily assess the effect of such events. © 2020 International Parkinson and Movement Disorder Society.
原发性家族性脑钙化(PFBC)是一种罕见的脑微血管钙化性疾病,具有多种神经精神表现。当携带致病性变异时,已有 5 个基因被报道为 PFBC 的致病原因。编码无机磷酸盐转运体的 SLC20A2 基因的单倍不足是常染色体显性遗传 PFBC 的主要原因。然而,在一部分患者中,PFBC 的遗传仍未得到解释,这表明存在其他基因或隐匿性突变。我们分析了 71 名无遗传相关性的、遗传原因不明的 PFBC 患者的外显子组测序数据,目的是检测可能破坏核心 PFBC 致病基因表达的拷贝数变异。
在鉴定出 SLC20A2 上游缺失后,我们通过逆转录滴式数字聚合酶链反应(RT-ddPCR)、体外无机磷酸盐摄取测定以及在人胚肾 293(HEK293)细胞中引入该区域假定的 SLC20A2 增强子缺失来评估其对基因功能的影响,该缺失位于该区域内。通过成簇规律间隔短回文重复序列(CRISPR)-CRISPR 相关蛋白 9(Cas9)。
在一个家族中与 PFBC 共分离的 8p11.21 缺失位于 SLC20A2 上游 35kb 处。缺失携带者/正常对照的相对 SLC20A2 mRNA 水平比值为 60.2%(P<0.001)。这与携带 SLC20A2 提前终止密码子的患者(63.4%;P<0.001)相当。先证者的血液无机磷酸盐摄取量减少了 39.3%(P=0.015)。在 HEK293 细胞中,我们观察到在 DNA 拷贝数归一化后,SLC20A2 mRNA 水平相对降低了 39.8%(P<0.001)。
我们鉴定出 SLC20A2 表达增强子的缺失,携带者表现出与功能丧失等位基因相似范围的单倍不足,并且我们在细胞模型中观察到该元件缺失后 mRNA 水平降低。我们提出了一种三步策略来识别和轻松评估此类事件的影响。
© 2020 国际帕金森病和运动障碍学会。